Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Serious Non-AIDS Conditions in HIV: Benefit of Early ART
Jens D Lundgren
, Alvaro H Borges, James D Neaton
Department of Clinical Medicine
8
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Serious Non-AIDS Conditions in HIV: Benefit of Early ART'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Non-AIDS Comorbidities
100%
Early Antiretroviral Therapy
100%
Antiretroviral Therapy
100%
Immune Impairment
75%
Metabolic
25%
Clinical Benefit
25%
Clinical Impact
25%
Preserved Renal Function
25%
Innate Immune Response
25%
Early Diagnosis
25%
Onward Transmission
25%
Anticancer Effect
25%
Oncogenic Process
25%
Cancer Risk
25%
Opportunistic Infections
25%
Early Infection
25%
HIV Infection
25%
Infection-related
25%
HIV-positive Adults
25%
Pro-oncogenic
25%
Human Following
25%
Randomized Trial
25%
Pulmonary Disease
25%
Neurocognitive Function
25%
Opportunistic Diseases
25%
Clinical Consequences
25%
Cancer Types
25%
No Adverse Effect
25%
Immune System
25%
Viral Replication
25%
Optimal Control
25%
System Influences
25%
Clear Effect
25%
Disease Outcome
25%
Antiretroviral Therapy Initiation
25%
Medicine and Dentistry
Human immunodeficiency virus
100%
Antiretroviral Therapy
100%
Immunity
44%
Infection
33%
Diseases
22%
Cancer
22%
Adverse Effect
11%
Silo-Filler's Disease
11%
Human Immunodeficiency Virus Infection
11%
Immune System
11%
Early Diagnosis
11%
Bacterial Infection
11%
Malignant Neoplasm
11%
Kidney Function
11%
Virus Replication
11%
Opportunistic Infection
11%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Infection
50%
Diseases
33%
Human Immunodeficiency Virus Infection
16%
Opportunistic Infection
16%
Malignant Neoplasm
16%
Bacterial Infection
16%
Lung Disease
16%
Immunology and Microbiology
Human immunodeficiency virus
100%
Immunity
66%
Viral Replication
16%
Immune System
16%
Kidney Function
16%
Human Immunodeficiency Virus Infection
16%
Opportunistic Infection
16%
Psychology
Neurocognitive Function
100%